Adaptive carbon ion radiotherapy for locally advanced non‐small cell lung cancer: Organ‐sparing potential and target coverage

BACKGROUND: The dose distribution of carbon ion radiotherapy (CIRT) for locally advanced non‐small cell lung cancer (LANSCLC) is highly sensitive to anatomical changes. PURPOSE: To demonstrate the dosimetric benefits of adaptive CIRT for LANSCLC and compare the differences between patients with and...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Shubing, Chen, Jian, Ma, Ningyi, Zhao, Jingfang, Mao, Jingfang, Jiang, Guoliang, Lu, Jiade, Wu, Kailiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
EMERGING IMAGING AND THERAPY MODALITIES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314958/
https://www.ncbi.nlm.nih.gov/pubmed/35192194
http://dx.doi.org/10.1002/mp.15563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314958/
https://www.ncbi.nlm.nih.gov/pubmed/35192194
http://dx.doi.org/10.1002/mp.15563

Ejemplares similares